Diagnostic Imaging Program

About Aestas Pharma

Aestas Pharma is a private, pre-clinical stage biotech founded in 2016 and headquartered in Durham, North Carolina, with a presence in San Diego. The company is developing a dual-platform strategy targeting Alzheimer's disease, combining diagnostic imaging agents with therapeutic small molecules to facilitate early detection and disease-modifying treatment. Operating pre-revenue, Aestas is positioned in the high-need, high-value Alzheimer's market but faces significant scientific, clinical, and competitive risks inherent to the neurology space. Its success hinges on advancing its pipeline from pre-clinical research into human clinical trials.

Therapeutic Areas

Other Early Detection of Alzheimer's Disease Drugs